APA (7th ed.) Citation

Ghosh, I., Gutka, H., Krause, M. E., Clemens, R., & Kashi, R. S. (2023). A systematic review of commercial high concentration antibody drug products approved in the US: Formulation composition, dosage form design and primary packaging considerations. mAbs, 15(1), 2205540. https://doi.org/10.1080/19420862.2023.2205540

Chicago Style (17th ed.) Citation

Ghosh, Indrajit, Hiten Gutka, Mary E. Krause, Ryan Clemens, and Ramesh S. Kashi. "A Systematic Review of Commercial High Concentration Antibody Drug Products Approved in the US: Formulation Composition, Dosage Form Design and Primary Packaging Considerations." MAbs 15, no. 1 (2023): 2205540. https://doi.org/10.1080/19420862.2023.2205540.

MLA (9th ed.) Citation

Ghosh, Indrajit, et al. "A Systematic Review of Commercial High Concentration Antibody Drug Products Approved in the US: Formulation Composition, Dosage Form Design and Primary Packaging Considerations." MAbs, vol. 15, no. 1, 2023, p. 2205540, https://doi.org/10.1080/19420862.2023.2205540.